Bone Marrow-Derived Mesenchymal Stem Cells Become Antiangiogenic When Chondrogenically or Osteogenically Differentiated: Implications for Bone and Cartilage Tissue Engineering
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.